Aio-studien-ggmbh
Clinical trials sponsored by Aio-studien-ggmbh, explained in plain language.
-
New combo therapy for lung cancer shows promise in early trial
Disease control OngoingThis study looks at whether it is safe and effective to continue the targeted therapy osimertinib while also giving radiation to patients with a type of lung cancer called EGFR-positive NSCLC. The trial includes 42 adults whose cancer has started to grow in a few spots (oligoprog…
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Could a painkiller boost chemo for tough colorectal cancers?
Disease control OngoingThis early-stage trial tests whether adding D,L-methadone (a pain medication) to standard chemotherapy (mFOLFOX6) can help control advanced colorectal cancer that has stopped responding to other treatments. The study involves 11 participants and aims to find the safest dose and m…
Phase: PHASE1, PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC